VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

PrV-HA (swine-origin H1N1)
Vaccine Information
  • Vaccine Name: PrV-HA (swine-origin H1N1)
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Vaccine Ontology ID: VO_0004698
  • Type: Recombinant vector vaccine
  • Status: Research
  • Host Species for Licensed Use: Baboon
  • HA gene engineering:
    • Type: Recombinant protein preparation
    • Description: Pseudorabies virus (PrV) strain Bartha (PrV-Ba) served as a vector for the expression of haemagglutinin (HA) of swine-origin H1N1 virus (Klingbeil et al., 2014).
    • Detailed Gene Information: Click Here.
  • Vector:
  • Preparation: The pseudorabies virus (PrV) strain Bartha (PrV-Ba) was used as vector for the expression of haemagglutinin (HA) of swine-origin H1N1 virus (Klingbeil et al., 2014).
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Pig Response

  • Vaccination Protocol: Piglets were infected intranasally with PrV-BaMI-synH1 as a live-virus vaccine, whereas control animals were immunized with PrV-Ba or not vaccinated (Klingbeil et al., 2014).
  • Vaccine Immune Response Type: VO_0003057
  • Challenge Protocol: A challenge with pandemic H1N1 SoIV A/California/7/09 performed 3 weeks after immunization (Klingbeil et al., 2014).
  • Efficacy: A single immunization of pigs with the PrV vector expressing the codon-optimized HA gene under control of P-MCMV induced high levels of HA-specific antibodies (Klingbeil et al., 2014).
References
Klingbeil et al., 2014: Klingbeil K, Lange E, Teifke JP, Mettenleiter TC, Fuchs W. Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus. The Journal of general virology. 2014; 95(Pt 4); 948-959. [PubMed: 24431235].